2024 MVP Prevention and Treatment of Infectious Disorders Including Hepatitis C and HIV (ID: M1368)

MVP ID: M1368

Most applicable medical specialty(s):
Infectious Disease, Immunology

The Prevention and Treatment of Infectious Disorders Including Hepatitis C and HIV MVP focuses on the clinical theme of promoting quality care for patients suffering from infectious disorders.


Improvement Activities

Report Two medium-weighted improvement activities or One high- weighted improvement activity:


Calculated by CMS using administrative claims data:

Population Health Measures

Select one population health measure to be scored by CMS using administrative claims data:

Promoting Interoperability

Report on the same PI measures required under traditional MIPS unless qualified for automatic reweighting or approved hardship exception:

MVP Registration

  • MVP Participants must register between April 1 – December 2, 2024 to report an MVP in 2024.
  • To register, MVP Participants must select:
    • The MVP they intend to report.
    • 1 population health measure included in the MVP.
    • Any outcomes-based administrative claims measures on which the MVP Participant intends to be scored (if available).
  • If reporting as a subgroup, registration must also include:
    • A list of Taxpayer Identification Numbers (TINs)/National Provider Identifiers (NPIs) in the subgroup;
    • A plain language name for the subgroup (which will be used for public reporting);
    • A description of the composition of the subgroup, which may be selected from a list or described in a narrative.
  • MVP Participants won’t be able to:
    • Submit/make changes to the MVP they select after the close of the registration period (December 2, 2024).
    • Report on an MVP they didn’t register for during the 2024 performance year.
    • Report on more than one MVP.

Register with MDinteractive